Pittsburgh Cure Sarcoma
Pittsburgh Cure Sarcoma is a charitable organization (also an educational organization) in Wexford, Pennsylvania.
Its tax id (EIN) is 84-3322815.
It was granted tax-exempt status by IRS in December, 2019.
For detailed information such as income and other financial data of Pittsburgh Cure Sarcoma, refer to the following table.
Profile of Pittsburgh Cure Sarcoma
| Organization Name |
Pittsburgh Cure Sarcoma
|
|---|
| Tax Id (EIN) | 84-3322815 |
|---|
| Address |
2731 Cole Rd,
Wexford,
PA
15090-7810
|
|---|
| In Care of Name | Mark Goodman |
|---|
|
All tax-exempt organizations in zip code 15090
|
| |
|---|
| Tax Period | Asset | Income | Revenue |
|---|
| 0 | $0 | $0 | $0 |
| December, 2019 | $0 | $0 | $0 |
| December, 2020 | $80,341 | $181,072 | $153,000 |
| December, 2021 | $226,017 | $253,386 | $229,229 |
| December, 2022 | $258,981 | $376,660 | $338,460 |
| December, 2023 | $195,631 | $333,076 | $294,066 |
| | | |
| IRS Exempt Status Ruling Date | December, 2019 |
|---|
| Exempt Status | Unconditional Exemption |
|---|
| Deductibility | Contributions are deductible |
|---|
| Tax Exempt Classification |
Diseases, Disorders, Medical Disciplines
|
|---|
| Tax Exempt Activity |
Cancer
|
|---|
| NTEE Code | G30 |
|---|
| Foundation Type | Organization which receives a substantial part of its support from a governmental unit or the general public 170(b)(1)(A)(vi) |
|---|
| Organization Type | Corporation |
|---|
| Organization Classification |
Charitable Organization
|
|---|
| Affiliation | Independent - This organization is an independent organization or an independent auxiliary (i.e., not affiliated with a National, Regional, or Geographic grouping of organizations). |
|---|
| Primary Return(s) Required to File | 990 (all other) or 990EZ return |
|---|
| Private Foundation Filing Requirement | No need to 990-PF return |
|---|
| Asset Range Reported on Form 990 | $100,000 to 499,999 |
|---|
| Income Range Reported on Form 990 | $100,000 to 499,999 |
|---|
| Accounting Period | 12 |
|---|
| | |
|---|